Medicare Enrolled
Dr. Alan Saven, M.D.
Hematology & Oncology · La Jolla, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Saven from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Saven?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Saven
Dr. Alan Saven is a hematology & oncology specialist in La Jolla, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Saven performed 105,389 Medicare services across 1,843 unique beneficiaries.
Between the years covered by Open Payments, Dr. Saven received a total of $437,278 from 56 pharmaceutical and/or device companies across 596 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Saven is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 7% volume in CA
$437,278 industry payments
Medicare Practice Summary
Medicare Utilization ↗105,389
Medicare services
Top 7% in CA for hematology & oncology
1,843
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~5,547 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
33,525 | $0 | $3 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
27,720 | $38 | $151 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
22,600 | $2 | $25 |
| Anti-nausea injection (aprepitant) | 5,590 | $1 | $7 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
5,580 | $22 | $209 |
| Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 3,090 | $38 | $126 |
| Injection, granisetron hydrochloride, 100 mcg | 2,180 | $0 | $3 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,236 | $98 | $350 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
794 | $0 | $1 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
424 | $14 | $55 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
360 | $119 | $479 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
360 | $81 | $1,806 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
238 | $150 | $491 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
234 | $137 | $453 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
202 | $56 | $236 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
190 | $6 | $39 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
151 | $31 | $114 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
139 | $12 | $45 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
129 | $25 | $100 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
96 | $18 | $72 |
| New patient office visit, complex (60-74 min) | 76 | $175 | $598 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
55 | $59 | $232 |
| Blood or blood product transfusion The administration of whole blood or specific blood components into a patient's bloodstream. |
52 | $36 | $157 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
52 | $4 | $41 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
46 | $50 | $200 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
45 | $1 | $41 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
43 | $26 | $104 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
41 | $81 | $359 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
40 | $22 | $94 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
36 | $155 | $706 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
30 | $25 | $110 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
19 | $90 | $354 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
16 | $2 | $10 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.8% high complexity
97.4% medium
1.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$437,278
Total received (2018-2024)
Avg $62,468/year across 7 years
Top 2% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
596
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$362,639 (82.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$70,228 (16.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,411 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$17,122
2023
$37,009
2022
$49,257
2021
$44,506
2020
$87,667
2019
$73,742
2018
$127,975
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
BeiGene USA, Inc.
$13,424
AstraZeneca Pharmaceuticals LP
$2,740
Alexion Pharmaceuticals, Inc.
$543
Gilead Sciences, Inc.
$107
ABBVIE INC.
$93
GlaxoSmithKline, LLC.
$89
SpringWorks Therapeutics, Inc.
$57
Daiichi Sankyo Inc.
$21
Sumitomo Pharma America, Inc.
$19
GENZYME CORPORATION
$16
Celgene Corporation
$15
Top 3 companies account for 97.6% of 2024 payments
All-time payments by company (2018-2024) ›
Incyte Corporation
$87,657
Celgene Corporation
$44,222
AstraZeneca Pharmaceuticals LP
$41,001
Pharmacyclics LLC, An AbbVie Company
$31,801
Karyopharm Therapeutics Inc.
$28,336
AbbVie, Inc.
$28,087
BeiGene USA, Inc.
$26,658
Janssen Biotech, Inc.
$25,730
Dova Pharmaceuticals
$21,388
GlaxoSmithKline, LLC.
$19,206
Takeda Pharmaceuticals U.S.A., Inc.
$18,242
AbbVie Inc.
$10,013
Sobi, Inc
$9,050
E.R. Squibb & Sons, L.L.C.
$8,660
Seattle Genetics, Inc.
$8,371
Amgen Inc.
$8,062
Pharmacyclics LLC, an AbbVie Company
$4,851
Lilly USA, LLC
$3,617
Kite Pharma, Inc.
$2,338
Novartis Pharmaceuticals Corporation
$2,157
Gilead Sciences, Inc.
$2,055
CTI BioPharma Corp.
$1,725
ABBVIE INC.
$1,449
AstraZeneca UK Limited
$832
Alexion Pharmaceuticals, Inc.
$543
Genentech USA, Inc.
$289
Teva Pharmaceuticals USA, Inc.
$131
PFIZER INC.
$121
Boehringer Ingelheim Pharmaceuticals, Inc.
$75
Daiichi Sankyo Inc.
$59
SpringWorks Therapeutics, Inc.
$57
Eisai Inc.
$41
GENZYME CORPORATION
$40
Sun Pharmaceutical Industries Inc.
$35
Ipsen Biopharmaceuticals, Inc
$30
Merck Sharp & Dohme Corporation
$29
ACCORD HEALTHCARE, INC.
$25
Seagen Inc.
$24
AMAG Pharmaceuticals, Inc.
$24
Rigel Pharmaceuticals, Inc.
$22
Partner Therapeutics, Inc.
$20
Mallinckrodt Enterprises LLC
$19
Sumitomo Pharma America, Inc.
$19
Exelixis Inc.
$16
CSL Behring
$16
TESARO, Inc.
$16
Spectrum Pharmaceuticals Inc.
$15
Clovis Oncology, Inc.
$15
West Therapeutics Development, LLC
$14
Advanced Accelerator Applications
$13
Jazz Pharmaceuticals Inc.
$12
Kyowa Kirin, Inc.
$12
Lexicon Pharmaceuticals, Inc.
$11
Epizyme, Inc.,
$11
Janssen Pharmaceuticals, Inc
$8
Secura Bio, Inc.
$7
Top 3 companies account for 39.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · Abraxane · Avastin · BENDEKA · BLENREP · BOSULIF · BRUKINSA · CALQUENCE · CAMCEVI · CELLEX/XTS PHOTOPHERESIS SYSTEM · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · EMPLICITI · EPKINLY · FERAHEME · Farydak · Folotyn · GAMIFANT · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INREBIC · Imbruvica · Inrebic · JADENU · JAKAFI · JEMPERLI · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LUMOXITI · LUTATHERA · LYNPARZA · Lazanda · Lenvima · Leukine · MYLOTARG · NINLARO · Neulasta · ODOMZO (sonidegib) capsules · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · Otezla · PADCEV · POTELIGEO · PROMACTA · Pomalyst · REBLOZYL · RYDAPT · Revlimid · Rituxan Hycela · Rubraca · SARCLISA · SOMATULINE DEPOT · SPRYCEL · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · Tavalisse · Turalio · ULTOMIRIS · VENCLEXTA · VYXEOS · Vanflyta · Venclexta · Vonjo · XARELTO · XPOVIO · Xermelo · YONSA · Yescarta · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (83%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for hematology & oncology in CA.
Geographic Context
Hematology & oncology specialists within 10 mi
138
Per 100K population
4.2
County median income
$102,285
Nearest hospital
SCRIPPS MEMORIAL HOSPITAL LA JOLLA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Saven is a mixed practice specialist, with above-average Medicare volume (top 7% in CA), with speaking/promotional industry engagement in the top 2% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Saven experienced with azacitidine chemotherapy injection?
Based on Medicare claims data, Dr. Saven performed 33,525 azacitidine chemotherapy injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Saven receive payments from pharmaceutical companies?
Yes. Dr. Saven received a total of $437,278 from 56 companies across 596 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Saven's costs compare to other hematology & oncology specialists in La Jolla?
Dr. Saven's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Saven) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in La Jolla
Browse hematology & oncology specialists in La Jolla ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology